Literature DB >> 14695088

Economic and social impacts of La Crosse encephalitis in western North Carolina.

J Todd Utz1, Charles S Apperson, J Newton MacCormack, Martha Salyers, E Jacquelin Dietz, J Todd McPherson.   

Abstract

La Crosse encephalitis (LACE), a human illness caused by a mosquito-transmitted virus, is endemic in western North Carolina. To assess the economic and social impacts of the illness, 25 serologically confirmed LACE case patients and/or families were interviewed to obtain information on the economic costs and social burden of the disease. The total direct and indirect medical costs associated with LACE over 89.6 life years accumulated from the onset of illness to the date of interview for 24 patients with frank encephalitis totaled dollar 791,374 (range = dollar 7,521-175,586), with a mean +/- SD per patient cost of dollar 32,974 +/- dollar 34,793. The projected cost of a case with lifelong neurologic sequelae ranged from dollar 48,775 to dollar 3,090,798 (n = 5). For the 25 LACE patients, 55.15 (54.83%) of the 100.59 cumulative life years (CLYs) were impaired to some degree. Disability adjusted life years (DALYs) were calculated to measure the productive life years lost to LACE. Approximately 13.00 DALYs were accumulated over 100.59 CLYs of study. Projected DALYs for case patients (n = 5) with lifelong neurologic sequelae ranged from 12.90 to 72.37 DALYs. An Impact of La Crosse Encephalitis Survey (ILCES) was used to measure the social impact of LACE over time for case patients and their families. The ILCES scores demonstrated that the majority of the social burden of the illness is borne by the five patients with lifelong neurologic sequelae. The socioeconomic burden resulting from LACE is substantial, which highlights the importance of the illness in western North Carolina, as well as the need for active surveillance, reporting, and prevention programs for the infection.

Entities:  

Mesh:

Year:  2003        PMID: 14695088

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

Review 1.  Emerging infectious diseases: the Bunyaviridae.

Authors:  Samantha S Soldan; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

Review 2.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.

Authors:  R S Bennett; A K Gresko; J T Nelson; B R Murphy; S S Whitehead
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 4.  North American wetlands and mosquito control.

Authors:  Jorge R Rey; William E Walton; Roger J Wolfe; C Roxanne Connelly; Sheila M O'Connell; Joe Berg; Gabrielle E Sakolsky-Hoopes; Aimlee D Laderman
Journal:  Int J Environ Res Public Health       Date:  2012-12-10       Impact factor: 3.390

5.  Cost-Effectiveness Study of Criteria for Screening Cerebrospinal Fluid To Determine the Need for Herpes Simplex Virus PCR Testing.

Authors:  Ronald G Hauser; Sheldon M Campbell; Cynthia A Brandt; Shiyi Wang
Journal:  J Clin Microbiol       Date:  2017-03-15       Impact factor: 5.948

6.  Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs.

Authors:  Gjon Blakqori; Friedemann Weber
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 7.  Impacts of climate, land use, and biological invasion on the ecology of immature Aedes mosquitoes: implications for La Crosse emergence.

Authors:  Paul T Leisnham; Steven A Juliano
Journal:  Ecohealth       Date:  2012-06-13       Impact factor: 3.184

8.  La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.

Authors:  Gjon Blakqori; Sophie Delhaye; Matthias Habjan; Carol D Blair; Irma Sánchez-Vargas; Ken E Olson; Ghassem Attarzadeh-Yazdi; Rennos Fragkoudis; Alain Kohl; Ulrich Kalinke; Siegfried Weiss; Thomas Michiels; Peter Staeheli; Friedemann Weber
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

9.  Bunyaviruses and the type I interferon system.

Authors:  Richard M Elliott; Friedemann Weber
Journal:  Viruses       Date:  2009-11-23       Impact factor: 5.048

10.  The demographic and socioeconomic factors predictive for populations at high-risk for La Crosse virus infection in West Virginia.

Authors:  Andrew D Haddow; Danae Bixler; Amy J Schuh
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.